Tag: Youquan Li
Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC
By Youquan Li, MD, FRCR, and Andrea Bezjak, MDCM, MSc, FRCPC
Posted: February 12, 2020
Targeted agents including TKIs of EGFR, ALK, and ROS1 have significantly...
